Brief: Ani Pharmaceuticals Announces The Launch Of Kionex® Suspension
20/05/2024 11:53
ANI Pharmaceuticals Inc ANIP.O :
* ANI PHARMACEUTICALS ANNOUNCES THE LAUNCH OF KIONEX®
SUSPENSION
* ANI PHARMACEUTICALS INC: LAUNCH OF KIONEX (SODIUM
POLYSTYRENE
SULFONATE SUSPENSION USP) FOR ORAL OR RECTAL USE
Source text for Eikon: ID:nGNX1Qhn5j
Further company coverage: ANIP.O
Recent news on ANI Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
ANI Pharmaceuticals Q1 revenue rises 21%, adjusted EPS beats estimates
Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma